EP08.02-042 EGFR-TKI +/- Antiangiogenics for EGFR-mutated Advanced NSCLC

Autor: da Silva, L.L. 1, Matsas, S. 2, Aguiar, P., Jr. 3, Taveira, G.M.T. 3, Barcelos, I.F. 3, Lopes, G.L., Jr. 4
Zdroj: In Journal of Thoracic Oncology September 2022 17(9) Supplement:S416-S417
Databáze: ScienceDirect